person

Manuel D. M. M.

Country
Spain
Department
Servicio de Cardiología

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 5 partner sites.

Specializations

Coronary Artery Disease & Revascularization

Focused on the diagnosis, interventional management, and long‑term outcomes of patients with obstructive coronary pathology.

  • Coronary Artery Disease in patients undergoing percutaneous coronary intervention
  • Assessment of stable coronary syndromes following successful PCI
  • Management of spontaneous coronary artery dissection in acute settings

Research integrates imaging, biomarker, and pharmacologic strategies to improve myocardial reperfusion and reduce recurrent events.

Heart Failure & Ventricular Dysfunction

Investigation of mechanisms and therapies for systolic heart failure across diverse etiologies.

  • Therapeutic evaluation in heart failure due to systemic left ventricular systolic dysfunction
  • Early intervention with candesartan to prevent left ventricular remodeling
  • Outcomes research in patients with advanced heart failure requiring device therapy

Emphasis on optimizing guideline‑directed medical therapy and novel agents to halt disease progression.

Genetic Cardiomyopathies & Inherited Cardiac Disorders

Targeted studies on hereditary conditions that predispose to cardiac dysfunction.

  • Screening of genetic carriers of dilated cardiomyopathy variants
  • Phenotypic characterization of familial hypertrophic cardiomyopathy
  • Risk stratification in arrhythmogenic right ventricular cardiomyopathy

Efforts aim to define early biomarkers and preventive strategies for at‑risk populations.

Vascular Medicine & Atherosclerotic Prevention

Study of systemic vascular health and primary prevention of atherothrombotic events.

  • Evaluation of primary prevention of atherosclerotic cardiovascular disease in high‑risk cohorts
  • Impact of lipid‑lowering therapies on major adverse cardiovascular events
  • Role of anti‑inflammatory agents in reducing vascular inflammation

Integrates clinical risk modeling with emerging therapeutic modalities.

Cardiac Imaging & Biomarker Development

Advancement of diagnostic tools to refine cardiovascular disease assessment.

  • Utilization of advanced echocardiography in cardiac remodeling detection
  • Validation of circulating troponin and NT‑proBNP as prognostic markers
  • Integration of cardiac MRI for tissue characterization in ischemic heart disease

Supports precision medicine approaches in cardiology.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.